Astragaloside IV Inhibits the Inflammatory Injury of Chicken Type II Pneumocytes Induced by Avian Pathogenic Escherichia coli

[1]  Xu-Bin Wei,et al.  Andrographolide interferes quorum sensing to reduce cell damage caused by avian pathogenic Escherichia coli. , 2014, Veterinary microbiology.

[2]  Xu-Bin Wei,et al.  Inhibitory effects of α-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes. , 2014, Veterinary immunology and immunopathology.

[3]  X. Chen,et al.  Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery. , 2013, International journal of pharmaceutics.

[4]  F. Huber,et al.  Emergent complexity of the cytoskeleton: from single filaments to tissue , 2013, Advances in physics.

[5]  É. Oswald,et al.  Diagnostic Strategy for Identifying Avian Pathogenic Escherichia coli Based on Four Patterns of Virulence Genes , 2012, Journal of Clinical Microbiology.

[6]  Wei Zhang,et al.  Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells , 2012, PloS one.

[7]  J. Ge,et al.  Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. , 2011, European journal of pharmacology.

[8]  Shouchuang Wang,et al.  Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma. , 2011, Planta medica.

[9]  M. Nordhoff,et al.  Avian pathogenic Escherichia coli MT78 invades chicken fibroblasts. , 2011, Veterinary microbiology.

[10]  P. Germon,et al.  The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. , 2011, Veterinary microbiology.

[11]  C. Shao,et al.  Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression , 2010, The Journal of Immunology.

[12]  Ji-Yeon Kim,et al.  Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. , 2008, International immunopharmacology.

[13]  H. Ji,et al.  Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. , 2007, European journal of pharmacology.

[14]  P. Rainard,et al.  Differential cytokine and chemokine responses of bovine mammary epithelial cells to Staphylococcus aureus and Escherichia coli. , 2007, Cytokine.

[15]  Y. Huang,et al.  Astragaloside IV Exerts Antiviral Effects Against Coxsackievirus B3 by Upregulating Interferon-γ , 2006, Journal of cardiovascular pharmacology.

[16]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[17]  T. Johnson,et al.  Characterizing the APEC pathotype. , 2005, Veterinary research.

[18]  Gerald Grütz,et al.  New insights into the molecular mechanism of interleukin‐10‐mediated immunosuppression , 2005, Journal of leukocyte biology.

[19]  G. Firestein,et al.  Proinflammatory Cytokine Expression in the Endolymphatic Sac During Inner Ear Inflammation , 2003, Journal of the Association for Research in Otolaryngology.

[20]  A. Akhand,et al.  Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells. , 2002, Cellular signalling.

[21]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[22]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[23]  A. Keshavarzian,et al.  Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor α in a human colonic cell line , 2000, Gut.

[24]  D. Marc,et al.  Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion. , 2000, Avian diseases.

[25]  M. Woodward,et al.  The role of fimbriae and flagella in the adherence of avian strains of Escherichia coli O78:K80 to tissue culture cells and tracheal and gut explants. , 2000, Journal of medical microbiology.

[26]  J. Fairbrother,et al.  Avian pathogenic Escherichia coli (APEC). , 1999, Veterinary research.

[27]  R. Pardi,et al.  Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. , 1997, The American journal of physiology.

[28]  M. Jordana,et al.  Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia , 1997, Gene Therapy.

[29]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  E. Ron,et al.  Adherence pili of avian strains of Escherichia coli O78 , 1990, Infection and immunity.

[31]  W. Yuan,et al.  Effect of astragalus membranaceus on electric activities of cultured rat beating heart cells infected with Coxsackie B-2 virus. , 1990, Chinese medical journal.

[32]  J. Maina,et al.  The thickness of avian blood-gas barrier: qualitative and quantitative observations. , 1982, Journal of anatomy.

[33]  C. Su,et al.  Astragaloside IV increases MMP-2 mRNA and protein expression in human lung cancer A549 cells. , 2009, Molecular medicine reports.